Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Burdett

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|July 22, 2014
Preoperative chemotherapy for non-small-cell lung cancer--authors' replySarah Burdett, Larysa H M Rydzewska, Jayne F Tierney, et al.
Plos Medicine|May 6, 2021
A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trialsJayne F Tierney, David J Fisher, Claire L Vale, et al.
Thorax|August 18, 2021
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic reviewHelen Hall, Adam Tocock, Sarah Burdett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancerAnne Aupérin, Cecile Le Péchoux, Estelle Rolland, et al.
The Lancet. Oncology|January 1, 2016
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate dataClaire L Vale, Sarah Burdett, Larysa H M Rydzewska, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysisLarysa H M Rydzewska, Sarah Burdett, Claire L Vale, et al.
European Urology|March 4, 2019
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysisSarah Burdett, Liselotte M Boevé, Fiona C Ingleby, et al.
The Lancet. Oncology|May 18, 2013
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' dataAudrey Mauguen, Jean-Pierre Pignon, Sarah Burdett, et al.
The Lancet. Oncology|July 6, 2023
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trialsClaire L Vale, David J Fisher, Peter J Godolphin, et al.
European Urology|June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate DataSarah Burdett, David J Fisher, Jayne F Tierney, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|July 22, 2014
Preoperative chemotherapy for non-small-cell lung cancer--authors' replySarah Burdett, Larysa H M Rydzewska, Jayne F Tierney, et al.
Plos Medicine|May 6, 2021
A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trialsJayne F Tierney, David J Fisher, Claire L Vale, et al.
Thorax|August 18, 2021
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic reviewHelen Hall, Adam Tocock, Sarah Burdett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancerAnne Aupérin, Cecile Le Péchoux, Estelle Rolland, et al.
The Lancet. Oncology|January 1, 2016
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate dataClaire L Vale, Sarah Burdett, Larysa H M Rydzewska, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysisLarysa H M Rydzewska, Sarah Burdett, Claire L Vale, et al.
European Urology|March 4, 2019
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysisSarah Burdett, Liselotte M Boevé, Fiona C Ingleby, et al.
The Lancet. Oncology|May 18, 2013
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' dataAudrey Mauguen, Jean-Pierre Pignon, Sarah Burdett, et al.
The Lancet. Oncology|July 6, 2023
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trialsClaire L Vale, David J Fisher, Peter J Godolphin, et al.
European Urology|June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate DataSarah Burdett, David J Fisher, Jayne F Tierney, et al.
Pageof 5